financetom
Business
financetom
/
Business
/
Australia's Central Bank Gets More Hawkish, Says SocGen
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australia's Central Bank Gets More Hawkish, Says SocGen
Aug 7, 2024 6:31 AM

09:03 AM EDT, 08/07/2024 (MT Newswires) -- At the policy meeting this week, the Reserve Bank of Australia (RBA) decided to leave the cash rate unchanged at 4.35%, as most people had anticipated, said Societe Generale.

The bank thinks that the policy statement has become a bit more hawkish than the previous meeting. The statement described the persistency of the recent trimmed mean inflation data in earnest, saying "In year-ended terms underlying inflation has now been above the midpoint of the target for 11 consecutive quarters, and quarterly underlying inflation has fallen very little over the past year."

It also gave a detailed explanation of the slight upward revision in trimmed mean inflation, saying "(it was) based on estimates that the gap between aggregate demand and supply in the economy is larger than previously thought."

In the concluding part, the statement added: "longer-term inflation expectations have been consistent with the inflation target , and policy will need to be sufficiently restrictive (until the Board is confident that inflation is moving sustainably towards the target range)."

In the press conference, Governor Michele Bullock gave a few more hawkish comments, including "a rate hike was discussed at today's meeting (the same as the last meeting)," and "policy rate cuts are off the table for this year (i.e., the RBA does not support the market's pricing of a December cut)."

An effective ruling out of a rate cut in the next six months supports SocGen's base scenario of the first rate cut in early 2025.

The RBA's Statement on Monetary Policy released also this week "significantly" raises gross domestic product (GDP) growth forecasts in 2025: Q2 forecast is revised up from 2.1% to 2.5% and Q4 forecast is up from 2.3% to 2.5%. Consumption and dwelling investment forecasts are revised down, while the RBA gets more bullish on business investment, public demand (probably reflecting the fiscal easing in the federal budget) and exports (despite the lingering concerns on China's slowdown).

The RBA expects slightly stronger employment growth and a tad higher unemployment rate (probably thanks to immigration), marginally higher wage growth and a considerable rise in productivity growth (due to GDP upgrades).

"Interestingly," the RBA introduces a sizeable tweak in headline inflation forecasts: Q4 2024 forecast is down from 3.8% to 3.0%, Q2 2025 forecast is down from 3.2% to 2.8%, Q4 2025 forecast is up from 2.8% to 3.7% and Q2 2025 forecast is up from 2.6% to 3.2%. This forecast revision reflects the likely changes in the government's cost-of-living measures such as electricity rebates and rent assistance.

Last, but not least, the RBA assumes a lower path of its own policy rates (from 4.2% and 3.9% to 4.0% and 3.6% for 2025, from 3.8% to 3.3% in Q2 2026), which now only reflects the financial market pricing (as such no longer contains the economists' survey), though the bank doesn't think that this assumption gives a meaningful impact on the official macroeconomic forecasts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merus Gets US FDA Approval for Bizengri in Advanced Pancreatic, Lung Cancers
Merus Gets US FDA Approval for Bizengri in Advanced Pancreatic, Lung Cancers
Dec 4, 2024
05:46 PM EST, 12/04/2024 (MT Newswires) -- Merus (MRUS) said late Wednesday that the US Food and Drug Administration has approved Bizengri for the treatment of adults with advanced unresectable or metastatic pancreatic adenocarcinoma or non-small cell lung cancer with a neuregulin 1, or NRG1, gene fusion, who have progressed after prior systemic therapy. These indications have been approved under...
EV investor Ideanomics files for bankruptcy to sell assets
EV investor Ideanomics files for bankruptcy to sell assets
Dec 4, 2024
NEW YORK, Dec 4 (Reuters) - Electric vehicle tech company Ideanomics Inc. ( IDEX ) filed for Chapter 11 bankruptcy in Delaware on Wednesday to find a buyer for its wireless charging business and other technology investments. Ideanomics ( IDEX ) entered bankruptcy with over $30 million in debt and just $189,000 in cash on hand, according to documents filed...
Crescent Energy Prices $400 Million Private Placement of Senior Notes
Crescent Energy Prices $400 Million Private Placement of Senior Notes
Dec 4, 2024
05:46 PM EST, 12/04/2024 (MT Newswires) -- Crescent Energy ( CRGY ) said late Wednesday it priced a $400 million private placement of 7.625% senior notes due 2032. The offering size was raised from the previously announced $300 million to $400 million. Net proceeds from the private placement will be used to fund the cash portion of Ridgemar's acquisition, reduce...
First Foundation Plans Secondary Offering of 70.3 Million Shares
First Foundation Plans Secondary Offering of 70.3 Million Shares
Dec 4, 2024
05:45 PM EST, 12/04/2024 (MT Newswires) -- First Foundation ( FFWM ) disclosed late Wednesday plans for a secondary offering of up to about 70.3 million shares. The company issued the securities to the selling stockholders as part of private placements closed on July 8. The selling stockholders may sell all or a portion of the securities from time to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved